Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity - PubMed (original) (raw)

Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity

M B Powell et al. Int Immunol. 1990.

Abstract

Lymphokine activity in seven myelin basic protein (MBP)-specific T cell clones was examined. All of the clones recognize MBP peptide 1-9 in the context of I-Au. A strong positive correlation was found between levels of lymphotoxin (LT) and tumor necrosis factor alpha (TNF-alpha) mRNA and biological activity on L929 cells and their capacity to induce paralysis, the clinical hallmark of experimental allergic encephalomyelitis (EAE). No correlation was found between interleukin-2 or gamma interferon production and encephalitogenicity. LT and/or TNF-alpha may play a central role in the pathogenesis of EAE.

PubMed Disclaimer

Similar articles

• Lymphokine production by encephalitogenic and non-encephalitogenic T-cell clones reactive to the same antigenic determinant.
  Tokuchi F, Nishizawa M, Nihei J, Motoyama K, Nagashima K, Tabira T. Tokuchi F, et al. J Neuroimmunol. 1990 Nov;30(1):71-9. doi: 10.1016/0165-5728(90)90054-q. J Neuroimmunol. 1990. PMID: 1699973
• Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
  Dittel BN. Dittel BN. Arch Immunol Ther Exp (Warsz). 2000;48(5):381-8. Arch Immunol Ther Exp (Warsz). 2000. PMID: 11140465 Review.
• Myelin specific, autoaggressive T cell clones in the normal immune repertoire: their nature and their regulation.
  Wekerle H. Wekerle H. Int Rev Immunol. 1992;9(3):231-41. doi: 10.3109/08830189209061793. Int Rev Immunol. 1992. PMID: 1285063 Review. No abstract available.

Cited by

• The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation.
  Richter F, Williams SK, John K, Huber C, Vaslin C, Zanker H, Fairless R, Pichi K, Marhenke S, Vogel A, Dhaen MA, Herrmann S, Herrmann A, Pfizenmaier K, Bantel H, Diem R, Kontermann RE, Fischer R. Richter F, et al. Front Immunol. 2021 Jul 7;12:705485. doi: 10.3389/fimmu.2021.705485. eCollection 2021. Front Immunol. 2021. PMID: 34305946 Free PMC article.
• Re-Examining the Role of TNF in MS Pathogenesis and Therapy.
  Fresegna D, Bullitta S, Musella A, Rizzo FR, De Vito F, Guadalupi L, Caioli S, Balletta S, Sanna K, Dolcetti E, Vanni V, Bruno A, Buttari F, Stampanoni Bassi M, Mandolesi G, Centonze D, Gentile A. Fresegna D, et al. Cells. 2020 Oct 14;9(10):2290. doi: 10.3390/cells9102290. Cells. 2020. PMID: 33066433 Free PMC article. Review.
• Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity.
  Richter F, Zettlitz KA, Seifert O, Herrmann A, Scheurich P, Pfizenmaier K, Kontermann RE. Richter F, et al. MAbs. 2019 Jan;11(1):166-177. doi: 10.1080/19420862.2018.1524664. Epub 2018 Oct 2. MAbs. 2019. PMID: 30252601 Free PMC article.
• TNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune Disease.
  Miller PG, Bonn MB, Franklin CL, Ericsson AC, McKarns SC. Miller PG, et al. J Immunol. 2015 Nov 15;195(10):4668-84. doi: 10.4049/jimmunol.1501664. Epub 2015 Oct 16. J Immunol. 2015. PMID: 26475926 Free PMC article.
• Antagonistic TNF receptor one-specific antibody (ATROSAB): receptor binding and in vitro bioactivity.
  Richter F, Liebig T, Guenzi E, Herrmann A, Scheurich P, Pfizenmaier K, Kontermann RE. Richter F, et al. PLoS One. 2013 Aug 19;8(8):e72156. doi: 10.1371/journal.pone.0072156. eCollection 2013. PLoS One. 2013. PMID: 23977237 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations

• Miscellaneous

  • NCI CPTAC Assay Portal